Rochester, NY 7/14/2009 2:51:46 AM
WhisperfromWallStreet.com Stock Report - CBM- Cambrex Regains Compliance With Revised NYSE Listing Standards
Cambrex Corp.
Cambrex Corp., CBM
Cambrex Corporation announced today that it has received notice from the New York Stock Exchange informing the Company that it is in compliance with the revised NYSE continued listing standards. As announced by the Company on April 14, 2009, the Company had failed to meet the NYSE continued listing standards because its average market capitalization over a consecutive 30-day period and total shareholders' equity had each fallen below the NYSE $75 million threshold.
ABOUT THE COMPANY
Cambrex Corporation, a life sciences company, provides products and services to develop and commercialize active pharmaceutical ingredients and advanced intermediates. Its products include active pharmaceutical ingredients and pharmaceutical intermediates for use in the production of prescription and over-the-counter drug products, and other custom chemicals derived from organic chemistry.
4.15 Up 0.05 (1.22%) 3:36PM ET
Last Trade: 4.16
Day's Range: 3.95 - 4.20
52wk Range: 1.48 - 8.29
Volume: 86,066
There are hundreds of stocks that rise and fall each day, our expertise is understanding which have the best opportunity for rapid growth. Our newsletter has sent out over 40 alerts this year with an average price gain of 80%. If you like to be alerted to the stocks that meets our criteria. Please join us for free to track our results.
You can sign up now for free stock alerts at WhisperfromWallStreet.com
Please read the COMPLETE DISCLAIMER posted on our website.
IMPORTANT NOTE: This is not a solicitation to buy or sell any securities. Neither WhisperfromWallStreet.com, nor any of its affiliates are registered investment advisors or a broker dealer. Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment.
